Pharma USA 2023: Digital Therapeutics and Pharma

Published on: 

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Related Content:

ConferencesPharma USAEditorial VideosStrategyPatient Engagement
Should Biopharma C-Suites Still Engage With China? A Harvard Business School Healthcare Alumni Association Q&A with Professor F. Warren McFarlan
Developing Patient-Focused Solutions: How a Multi-Modality Approach to Drug Discovery and Development is Driving Transformative Innovation
Medical Debts in America: Collections, Aggressive Tactics, and Consequences